Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Ivermectin; Praziquantel
Norbrook Laboratories (Ireland) Limited
QP54AA51
Ivermectin; Praziquantel
18.7, 140.3 milligram(s)/gram
Oral paste
POM: Prescription Only Medicine as defined in relevant national legislation
ivermectin, combinations
Authorised
2013-09-27
Health Products Regulatory Authority 01 April 2019 CRN008Z7Z Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Iverpraz, 18.7 mg/g + 140.3 mg/g Oral Paste for Horses 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram contains: ACTIVE SUBSTANCE: Ivermectin 18.7 mg Praziquantel 140.3 mg EXCIPIENT(S): Titanium Dioxide (E171) 20 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral paste. A white to off white homogenous paste. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mixed cestode and nematode or arthropod infestations, due to adult and immature roundworms, lungworms, bots and tapeworms in horses: NEMATODES: Large strongyle: _Strongylus vulgaris_ (adult and arterial larvae), _Strongylus edentatus_ (adult and L4 tissue larval stages) _Strongylus equinus_ (adult), _Tridontophorus_ spp. (adult) Small strongyle: Cyathostomum: _Cylicocyclus_ spp., _Cylicostephanus_ spp., _Cylicodontophorus_ spp., _Gyalocephalus_ spp. (adult and non-inhibited mucosal larvae) Parascaris: _Parascaris equorum_ (adult and larvae) Oxyuris: _Oxyuris equi_ (larvae) Trichostrongylus: _Trichostrongylus axei_ (adult) Strongyloides: _Strongyloides westeri_ (adult) Habronema: _Habronema_ spp. (adult) Onchocerca: _Onchocerca_ spp. microfilariae i.e. cutaneous onchocerciasis Lungworm: _Dictyocaulus arnfieldi_ (adult and larvae) CESTODES (Tapeworm): _Anoplocephala perfoliata_ (adult), _Anoplocephala magna _(adult), _Paranoplocephala mamillana_ (adult) _ _ DIPTERAN INSECTS: _Gasterophilus_ spp. (larvae) Health Products Regulatory Authority 01 April 2019 CRN008Z7Z Page 2 of 5 4.3 CONTRAINDICATIONS Do not use in foals under 2 weeks of age. Do not use in case of hypersensitivity to the active substances or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of developmen Soma hati kamili